Obturator Nerve Block in Total Hip Arthrosplasty
NOCH
1 other identifier
interventional
60
1 country
1
Brief Summary
Interest of obturator nerve block for analgesia in total hip arthroplasty remains controversial. This regional anesthesia procedure could provide post-operative pain relief as obturator nerve is responsible for innervation of the internal part of the hip joint capsule. This randomized double-blind study aims to assess obturator nerve block for post-operative analgesia in total hip arthroplasty. Before the surgery, an ultrasound guided obturator nerve block will be performed with either 20cc of saline or ropivacaine 0.2% (a long-acting local anesthetics). After regional anesthesia, a general anesthesia will be performed for intraoperative period. This study aims to assess post-operative pain management during the first 24 hours. Ability to walk the day of the surgery will also be collected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 3, 2019
CompletedFirst Posted
Study publicly available on registry
September 11, 2019
CompletedStudy Start
First participant enrolled
January 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 22, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 22, 2020
CompletedDecember 14, 2020
December 1, 2020
8 months
September 3, 2019
December 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oxycodone requirement in PACU
In the PACU, patients will be assessed for pain using a verbal rating scale (VRS) (VRS, 0=no pain, 10=worst pain). Patients suffering from pain (VRS \> 4/10) will receive oxycodone 2 mg intravenous boluses / 3 minutes. Oxycodone requirement will be compared between interventional and control groups.
Length of stay in PACU
Secondary Outcomes (4)
Pain assessement
Postoperative period : maximum 24 hours after surgery
Postoperative Oxycodone consumption
Postoperative period : maximum 24 hours after surgery
Ability to walk
Postoperative period : maximum 24 hours after surgery
Side effects of opioids
Postoperative period : maximum 24 hours after surgery
Study Arms (2)
Obturator nerve block with Ropivacaine
EXPERIMENTALObturator nerve block will be performed before general anesthesia as descripted by Nielsen (RAPM, 2019). A linear transducer will be oriented in the transverse plane and placed in the inguinal crease. The tail of the transducer will be tilted distal in order to visualize the pectineus muscle (medial to the femoral vessels) at its insertion at the superior pubic ramus superficial to the external obturator muscle. An 80 mm nerve block needlewill be inserted in-plane from the lateral end of the transducer and advanced until the tip of the needle will be inside the interfascial plane between the pectineus and the obturator externus muscles. 20 milliliters of ropivacaine 2 mg/mL will be injected in the interfacial plane between the pectineus and external obturator muscles.
Obturator nerve block with isotonic salin
SHAM COMPARATORThe same procedure will be performed and 20 milliliters of isotonic saline will be injected in the interfacial plane between the pectineus and external obturator muscles
Interventions
20 milliliters of ropivacaine 2 mg/mL will be injected in the interfacial plane between the pectineus and external obturator muscles.
20 milliliters of isotonic saline will be injected in the interfacial plane between the pectineus and external obturator muscles.
Eligibility Criteria
You may qualify if:
- years and older
- Primary THA under general anesthesia
- Consent for participation
- Affiliation to the french social security system
You may not qualify if:
- Revision of hip arthroplasty
- Significant psychiatric disturbances
- Minor patient
- Pregnancy
- Breastfeeding
- Contraindication to any drug used in the protocol: acetaminophen, ketoprofen, nefopam, oxycodone, propofol, ketamine, Ropivacaine…
- Chronic pain
- Current use oral morphine or equivalents
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinique Medipole Garonne
Toulouse, 31036, France
Related Publications (1)
Marty P, Chassery C, Rontes O, Vuillaume C, Basset B, Merouani M, Marquis C, Delussy A, Delbos MC, Ferre F, Bataille B, Joshi G, Delbos A. Obturator nerve block does not provide analgesic benefits in total hip arthroplasty under multimodal analgesic regimen: a randomized controlled trial. Reg Anesth Pain Med. 2021 Aug;46(8):657-662. doi: 10.1136/rapm-2021-102531. Epub 2021 May 5.
PMID: 33952684DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 3, 2019
First Posted
September 11, 2019
Study Start
January 14, 2020
Primary Completion
September 22, 2020
Study Completion
September 22, 2020
Last Updated
December 14, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share